Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42.9M
-
Number of holders
-
266
-
Total 13F shares, excl. options
-
49.8M
-
Shares change
-
-550K
-
Total reported value, excl. options
-
$3.49B
-
Value change
-
-$29M
-
Put/Call ratio
-
0.37
-
Number of buys
-
111
-
Number of sells
-
-124
-
Price
-
$70.09
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2021
300 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 266 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.8M shares
.
Largest 10 shareholders include BlackRock Inc. (7.17M shares), VANGUARD GROUP INC (4.51M shares), MACQUARIE GROUP LTD (3.29M shares), RENAISSANCE TECHNOLOGIES LLC (2.31M shares), BAILLIE GIFFORD & CO (2.1M shares), Spyglass Capital Management LLC (1.98M shares), WELLS FARGO & COMPANY/MN (1.57M shares), STATE STREET CORP (1.43M shares), PAULSON & CO. INC. (1.41M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares).
This table shows the top 266 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.